MedPath

Feasibility, Acceptability, and Safety of Neonatal Male Circumcision in Lusaka, Zambia

Phase 4
Completed
Conditions
Neonatal Male Circumcision
Interventions
Procedure: Neonatal male circumcision
Registration Number
NCT01115335
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

In this study of neonatal male circumcision (NMC), the investigators will examine acceptability of among parents, feasibility of training providers and implementing services in various clinical settings, and the safety of service provision comparing three different surgical methods: the Gomco; the Plastibell; and the Mogen clamp. This operational study is being conducted to inform the scale up of neonatal male circumcision in Zambia.

Detailed Description

As male circumcision becomes one component of Zambia's plan to prevent the spread of HIV, it is important to understand the acceptability, feasibility, and safety of implementing NMC services in various clinical settings.

In this study, we will examine the acceptability of neonatal male circumcision among parents in several ways. First, we will administer a structured questionnaire on NMC to 1000 consenting parents of newborn boys at a tertiary care institution and 1-2 primary care clinics in Lusaka. All parents approached, regardless of whether or not they complete the survey, will also be offered an opportunity to have their sons circumcised. Uptake will be calculated as the percent of parents approached who consent for their sons to be circumcised. Finally, we will assess parental satisfaction with results of the procedure.

To examine the feasibility of training providers and implementing neonatal male circumcision services in various clinical settings, we will train a group of 15-20 health care providers in three different circumcision methods (Gomco clamp, Mogen clamp, and Plastibell) at 2-3 study sites. We will recruit 600 infants to be circumcised during the training. We will use structured questionnaires and skill assessments to evaluate provider competence after completing the training curriculum, provider preferences among the three circumcision methods, and opinion about how NMC should be scaled up within the existing health care system. We will also document logistical difficulties of scaling up NMC services at the study sites.

Finally, we will examine the safety of implementing NMC by collecting and analyzing data on complications resulting from the different circumcision methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
661
Inclusion Criteria
  • Male infants who are in the first day of life (including infants < 24 hours old) and up to 4 weeks of age will be considered for circumcision
  • Gestational age >37 weeks at birth
Exclusion Criteria
  • Any current illness
  • Bleeding diathesis or family history of bleeding disorder
  • Abnormality of urethra or penile shaft such as hypospadias
  • Local infection defined as redness, swelling, or a purulent discharge from the infant penis
  • Greater than four weeks of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GomcoNeonatal male circumcisionNMC performed using a Gomco clamp
Mogen clampNeonatal male circumcisionNMC performed using a Mogen clamp
PlastibellNeonatal male circumcisionNMC performed using a Plastibell device
Primary Outcome Measures
NameTimeMethod
Complication Rate0-6 weeks after the circumcision procedure

Includes intra-operative and post-operative complications such as bleeding, infection, and cosmetic problems

Secondary Outcome Measures
NameTimeMethod
Uptake of NMCOngoing, over the course of the study (1.5 years)

Defined as % of parents of newborn boys approached during recruitment who consent to having their sons cirucumcised

Provider PreferencesUpon completion of training in NMC

Measure of provider preferences among 3 circumcision devices being compared

Parent Satisfaction6 weeks following the circumcision procedure

Score, between 0 and 100, of each parent's satisfaction with the outcome of the NMC procedure

Trial Locations

Locations (1)

University Teaching Hospital and Matero Reference Clinic

đŸ‡¿đŸ‡²

Lusaka, Zambia

© Copyright 2025. All Rights Reserved by MedPath